logo
logo

Oxford Gene Technology


Founded by Professor Ed Southern, Oxford Gene Technology (OGT) is focused on providing innovative clinical genetics and diagnostic solutions to advance molecular medicine.

OGT’s innovative portfolio includes:

CytoSure™ — Providing clinical researchers with the complete array solution for the detection of chromosomal abnormalities, including class-leading products and fully accredited services, underpinned by exceptional interpretation software.

Genefficiency™ — Delivering comprehensive, high-quality microarray and targeted sequencing services to clinical and academic researchers.

Diagnostic Biomarkers — Providing tailored biomarker discovery solutions that optimise drug and diagnostic development programmes for pharmaceutical and molecular diagnostic companies.